Biomedical Research

Featured Items

Unproven Stem Cell therapies
Neglected Diseases: policy priorities
Drawing the Line: Ethical, Political and Scientific Perspectives on U.S. Embryo Research
 

var BM = [ {thumb:'/photos/625/72x66/crop/90/',image:'/media/cached/photos/625/640x640/constrain/90//opt/webapps/orgs/tendenci_site/media/photos/3022286a/BI-image-StemCellTourism-092216-4-301fb.jpg',big:'/photos/625/800x800/constrain/90/',title:'Panelists speak with audience members after the event on the ethics of stem cell tourism.',description:''}, {thumb:'/photos/626/72x66/crop/90/',image:'/media/cached/photos/626/640x640/constrain/90//opt/webapps/orgs/tendenci_site/media/photos/5f58a74e/BI-image-StemCellTourism-092216-1-5f566.jpg',big:'/photos/626/800x800/constrain/90/',title:'Panel members respond to audience questions during an event on stem cell tourism.',description:''}, {thumb:'/photos/623/72x66/crop/90/',image:'/media/cached/photos/623/640x640/constrain/90//opt/webapps/orgs/tendenci_site/media/photos/2dd21b88/BI-image-StemCellTourism-092216-2-2dcf4.jpg',big:'/photos/623/800x800/constrain/90/',title:'James T. Willerson, president and director of Cardiology Research, and co\u002Ddirector of Cullen Cardiovascular Research Laboratories at the Texas Heart® Institute, considers the risks of stem cell tourism.',description:''}, {thumb:'/media/cached/photos/619/72x66/crop/90/BI-image-Biden-091616-3-54502.jpg',image:'/media/cached/photos/619/640x640/constrain/90/BI-image-Biden-091616-3-54502.jpg',big:'/media/cached/photos/619/800x800/constrain/90/BI-image-Biden-091616-3-54502.jpg',title:'Former Secretary of State James A. Baker, III, honorary chair of the Baker Institute, offers welcoming remarks onstage next to Vice President Biden and Second Lady Dr. Jill Biden.',description:''}, {thumb:'/media/cached/photos/620/72x66/crop/90/BI-image-Biden-091616-6-54ead.jpg',image:'/media/cached/photos/620/640x640/constrain/90/BI-image-Biden-091616-6-54ead.jpg',big:'/media/cached/photos/620/800x800/constrain/90/BI-image-Biden-091616-6-54ead.jpg',title:'Vice President Joe Biden announces the rollout of trials.cancer.gov, a user\u002Dfriendly site that offers patients more complete and up\u002Dto\u002Ddate information about clinical trials across the nation to improve access to treatment.',description:''}, {thumb:'/media/cached/photos/621/72x66/crop/90/BI-image-Biden-091616-8-55bc8.jpg',image:'/media/cached/photos/621/640x640/constrain/90/BI-image-Biden-091616-8-55bc8.jpg',big:'/media/cached/photos/621/800x800/constrain/90/BI-image-Biden-091616-8-55bc8.jpg',title:'A packed audience of Rice University students, Baker Institute members, MD Anderson representatives and invited guests fill Tudor Fieldhouse to hear Vice President Joe Biden’s remarks on the White House Cancer Moonshot Initiative.',description:''}, {thumb:'/media/cached/photos/622/72x66/crop/90/BI-image-Biden-091616-13-567eb.jpg',image:'/media/cached/photos/622/640x640/constrain/90/BI-image-Biden-091616-13-567eb.jpg',big:'/media/cached/photos/622/800x800/constrain/90/BI-image-Biden-091616-13-567eb.jpg',title:'Vice President Joe Biden poses for a picture while holding up a thyroid cancer T\u002Dshirt given to him by an audience member.',description:''}, {thumb:'/media/cached/photos/403/72x66/crop/90/BI-MendelsohnLecture-020416-FB-de91d.jpg',image:'/media/cached/photos/403/640x640/constrain/90/BI-MendelsohnLecture-020416-FB-de91d.jpg',big:'/media/cached/photos/403/800x800/constrain/90/BI-MendelsohnLecture-020416-FB-de91d.jpg',title:'John Mendelsohn (right), the L.E. and Virginia Simmons Fellow in Health and Technology Policy, and Daniel Wagner, Rice faculty scholar, discuss drug development and design for the course BIOC 447/547 \u0022The Future of Medicine.\u0022',description:''}, {thumb:'/media/cached/photos/273/72x66/crop/90/8-DePinho_STPolicy-df24d.jpg',image:'/media/cached/photos/273/640x640/constrain/90/8-DePinho_STPolicy-df24d.jpg',big:'/media/cached/photos/273/800x800/constrain/90/8-DePinho_STPolicy-df24d.jpg',title:'Ronald DePinho, president of MD Anderson Cancer Center, introduces the panelists for the sixth event in the Medicine, Research and Society Policy Issues Series on “HPV Vaccination: A Public Health Opportunity, a Public Responsibility.”',description:''}, {thumb:'/media/cached/photos/279/72x66/crop/90/21-hiPSC1-BRC-e2f4d.jpg',image:'/media/cached/photos/279/640x640/constrain/90/21-hiPSC1-BRC-e2f4d.jpg',big:'/media/cached/photos/279/800x800/constrain/90/21-hiPSC1-BRC-e2f4d.jpg',title:'Normal human cells reprogrammed to be induced pluripotent stem cells (iPS). Blue stain indicates cell nucleus. Green and red mark for pluripotency proteins expressed on the surface of the cells. Image courtesy of Matt Spindler in the lab of Deepak Srivastava, Gladstone Institutes.',description:''}, {thumb:'/media/cached/photos/280/72x66/crop/90/22-mESC_ReN1b-BRC-e3ab4.jpg',image:'/media/cached/photos/280/640x640/constrain/90/22-mESC_ReN1b-BRC-e3ab4.jpg',big:'/photos/280/800x800/constrain/90/',title:'Neurons generated from mouse embryonic stem cells (ESC), with the nucleus (blue) and spindly structures that transmit electricity between cells (green) shown. Image courtesy of Ethan Hua in the lab of Deepak Srivastava, Gladstone Institutes. ',description:''}, {thumb:'/media/cached/photos/281/72x66/crop/90/23-miPSC_ReCM8-DS-e4771.jpg',image:'/media/cached/photos/281/640x640/constrain/90/23-miPSC_ReCM8-DS-e4771.jpg',big:'/photos/281/800x800/constrain/90/',title:'Heart muscle cells reprogrammed from another type of heart cell, in a living mouse heart. Image courtesy of Li Qian in the lab of Deepak Srivastava, Gladstone Institutes.',description:''} ]

About the program

The Baker Institute Biomedical Research Program provides policymakers, scholars, scientists and the general public with research and analyses on emerging issues facing scientists and clinicians as biomedical research moves from laboratories to patients. The program addresses key areas, including the funding and sustainability of the U.S. biomedical research infrastructure; the ethical, political and regulatory challenges of emerging biomedical technologies; and the cost and benefits of bringing new and innovative treatments and therapies to clinics.

Read more about the Biomedical Research Program

Fellows & Scholars ยป

John Mendelsohn

John Mendelsohn, M.D., is a Nonresident Fellow in Biomedical Research Policy at the Baker Institute. His work focuses on the identification and evaluation of ...
Read more about this expert

Kirstin R.W. Matthews

Kirstin R.W. Matthews, Ph.D., is a fellow in science and technology policy at the Baker Institute. She is also a lecturer in the Wiess ...
Read more about this expert